Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 Visualizzazioni
• 07/17/23
0
0
Incorporare
administrator
Iscritti
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti